tested the hypothesis that emergency revascularization for cardiogenic shock due to an ST-elevation/Q-wave or new left bundle branch block MI would result in reduction in all-cause 30-day ...

Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

As a result of the initiative, the hospital now participates in the national cardiogenic shock registry created by the American Heart Association to standardize care, increase collaboration, and ...